{{Rsnum
|rsid=7172432
|Chromosome=15
|position=62104190
|Orientation=plus
|GMAF=0.4972
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.1 | 39.8 | 22.1
| HCB | 27.7 | 53.3 | 19.0
| JPT | 29.5 | 56.2 | 14.3
| YRI | 7.5 | 38.8 | 53.7
| ASW | 7.0 | 47.4 | 45.6
| CHB | 27.7 | 53.3 | 19.0
| CHD | 40.4 | 45.0 | 14.7
| GIH | 33.7 | 54.5 | 11.9
| LWK | 8.2 | 40.0 | 51.8
| MEX | 27.6 | 48.3 | 24.1
| MKK | 11.0 | 38.3 | 50.6
| TSI | 49.0 | 40.2 | 10.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20818381
|Trait=None
|Title=A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B
|RiskAllele=
|Pval=9E-14
|OR=1.11
|ORtxt=[1.08-1.14]
}}

{{PMID Auto
|PMID=21249489
|Title=The diabetogenic VPS13C/C2CD4A/C2CD4B rs7172432 variant impairs glucose-stimulated insulin response in 5,722 non-diabetic Danish individuals
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}